(Q36707618)

15 August 2017

1 reference

title

Gene therapy for restenosis: biological solution to a biological problem (English)

1 reference

15 August 2017

0 references

Raj Kishore

1

1 reference

15 August 2017

Douglas W Losordo

series ordinal

2

1 reference

15 August 2017

publication date

11 January 2007

1 reference

Journal of Molecular and Cellular Cardiology

15 August 2017

published in

1 reference

15 August 2017

volume

42

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

461-468

1 reference

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Antiproliferative strategies for the treatment of vascular proliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene and cell-based therapies for heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Experimental models of coronary artery restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene therapy for coronary restenosis: is the enthusiasm justified?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Recombinant gene expression in vivo within endothelial cells of the arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Retroviral suicide vector does not inhibit neointimal growth in a porcine coronary model of restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenovirus-mediated transfer of ribozyme targeting platelet-derived growth factor A-chain mRNA inhibits growth of vascular smooth muscle cells from spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Images in cardiovascular medicine. False aortic aneurysm due to rupture of an aortocoronary saphenous vein bypass graft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Engineering the response to vascular injury: divergent effects of deregulated E2F1 expression on vascular smooth muscle cells and endothelial cells result in endothelial recovery and inhibition of neointimal growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Inhibition of neointimal formation in porcine coronary artery by a Ras mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

In vivo gene transfer: prevention of neointima formation by inhibition of mitogen-activated protein kinase kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene therapy for restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Nitric oxide. Novel biology with clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

New frontiers in interventional cardiology: intravascular radiation to prevent restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Pleiotropic effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Histopathology of in-stent restenosis in patients with peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Pathological analysis of local delivery of paclitaxel via a polymer-coated stent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Morphology of the endothelium over atherosclerotic plaques in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.11.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YJMCC.2006.11.012

1 reference

15 August 2017

1 reference